The underivatized alkaloid mixture extracted from the bulbs of Chlidanthus fragrans Herb. was investigated by capillary GC/MS for the first time. Fifteen known Amaryllidaceae alkaloids of five structure types were identified. The main alkaloids were tazzetine (9, tazettine-type), chlidanthine (2, galanthamine-type), belladine (8, belladine-type) and lycorine (12, lycorine-type). The alkaloid extract from the bulbs showed promising human blood acetylcholinesterase (IC 50 = 20.1 ± 2.9 μg/mL) and human plasma butyrylcholinesterase (IC 50 = 136.8 ± 6.9 μg/mL) inhibitory activity.
Chlidanthus fragrans Herb. is a bulbous plant belonging to the family Amaryllidaceae. The genus Chlidanthus includes ten species of tender bulbs from tropical South America, mostly native to the Andes. The botanical name comes from the Greek, meaning "delicate flower" [1] . Plants of the Amaryllidaceae family are known to synthesize a particular type of bioactive compounds named Amaryllidaceae alkaloids [2] . Some species of this family contain galanthamine, an acetylcholinesterase inhibitor approved for the treatment of Alzheimer´s disease [3, 4] , as well as other alkaloids with interesting pharmacological activities, such as anticancer, antiviral, antimalarial, antioxidant and antitumor [5] [6] [7] .
There have been two previous phytochemical investigations of Ch. fragrans. From the bulbs, four alkaloids (galanthamine, chlidantine, tazettin and lycorin) were isolated [8, 9] . Methanol and toluene extracts of the bulbs were tested for their acetylcholinesterase inhibition using the microplate assay, and the TLC assay with acetylcholinesterase from electric eel [10] . This study showed inhibition activity of both extracts in the microplate assay and also showed several inhibiting 'spots' in the TLC assay. However, the chemical composition of these 'spots, was not determined.
Alzheimer´s disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills. In most people with AD, the first symptoms appear after the age of 60. In AD patients, deficit of cholinergic functions, which results in decreased levels of the neurotransmitter acetylcholine (ACh) in the cortex, is responsible for the memory impairments [11] . The principal role of acetylcholinesterase (AChE) is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of acetylcholine (ACh). Inhibition of AChE serves as a strategy for the treatment of AD, senile dementia, ataxia, myasthenia gravis and Parkinson´s disease [12] . Moreover, in late AD stages, levels of AChE have declined by up to 85% and BuChE represents the predominant cholinesterase in the brain. BuChE, primarily associated with glial cells, but also with specific neuronal pathways, cleaves ACh in a manner similar to that of AChE to terminate its physiological action [13] . This fact has targeted BuChE as a new approach to intercede in the progression of AD and requires research of new inhibitors with dual enzymatic activity. Currently, cholinesterase inhibition is the most used therapeutic treatment for the symptoms of AD [14, 15] . Natural compounds from various structural classes, such as alkaloids (Amaryllidaceae, isoquinoline, steroidal), coumarins, terpenoids and their synthetic analogs have shown AChE and partial BuChE inhibitory activity [16] [17] [18] [19] .
In the present work we report the results of a GC/MS investigation of the alkaloid extract from the bulbs of Ch. fragrans and the inhibitory effects of the initial ethanolic This initial extract of the bulbs was concentrated into an alkaloid fraction and, as expected, the results showed that the alkaloid fraction possesses promising bioactivity, with an IC 50 of 20.1 ± 2.9 μg/mL for HuAChE, and 136.8 ± 6.9 μg/mL for HuBuChE.
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In order to identify the compounds in the complex alkaloid fraction of the bulbs of Ch. fragrans, capillary GC/MS was employed. Derivatization was not required, since the Amaryllidaceae alkaloids retain their characteristic EI/MS fragmentation patterns, which are very similar to those obtained under direct insertion [20, 21] . In the bulb extract, fifteen alkaloids of five structural types of Amaryllidaceae alkaloids were detected by GC/MS. The compounds were identified from their retention times (RT) and mass spectra as galanthamine (1, galanthamine-type), chlidanthine (2, galanthamine-type), buphanisine (3, crinine-type), narwedine (4, galanthamine-type), belladine (5, belladinetype), 6-deoxytazettine (6, tazettine-type), N-demethylbelladine (7, belladine-type), 6-O-methylpretazzetine (8, tazzetine-type), tazzetine (9, tazettine-type), undulatine (10, crinine-type), lycorine (11, lycorine-type), ambelline (12, crinine-type), 3-epimacronine (13, tazettine-type), acetylnerbowdine (14, crinine-type), and bowdesine (15, crinine-type) ( Table 1) . Compounds 3-8, 10 and 12-15 are reported for the first time in the genus Chlidanthus. Compound 8 (6-O-methylpretazettine) showed a mass spectrum similar to that of tazettine, and its fragmentation pattern was congruent with a β-configuration of the methoxyl group at the C-3 position. The spectrum of this alkaloid was not available in the NIST 08 library, but the fragmentation was identical with that reported in the literature [22] . This compound has already been isolated from Eucharis amazonica (Amaryllidaceae) [22] . Alkaloids of the belladine structure type, which are biosynthetic precursors of Amaryllidaceae alkaloids [23] , have been previously reported only in the genera Crinum and Nerine [24] .
The relative proportion of each alkaloid was determined as a percentage of the total ion current. The major components were tazettine (9; 48% of TIC), chlidanthine (2; 17% of TIC), belladine (5; 8% of TIC) and lycorine (12; 7% of TIC) ( Table 1 ). The area of the GC/MS peaks depends not only on the corresponding compounds, but also on the intensity of their MS fragmentation, so the data given in the table are not true quantification. However, they can be used for comparison between samples.
It is known that, among species of Amaryllidaceae, AChE inhibitory activity is associated mainly with galanthamine and lycorine-type alkaloids [17, 26] . Lycorine-type compounds are less active inhibitors than the galanthamine-type and their activity is associated with substitution at positions C-1 and C-2 [17] . Amaryllidaceae alkaloids from the bulbs of Chlidanthus fragrans Natural Product Communications Vol. 6 (5) 2011 605
We found relatively high levels of galanthamine and lycorine-type compounds in the alkaloid mixture (up to34%). Therefore, the presence of the compounds mentioned above could explain the AChE inhibitory activity of the extract of Ch. fragrans. There are no data in the literature about the AChE and BuChE inhibitory activity of some of the alkaloids found in this plant species, and that is why the isolation of these compounds would be interesting due to their potential activity as an AChE, BuChE or AChE/BuChE inhibitor.
Experimental

Plant materials:
The fresh bulbs of Ch. fragrans Herb. were obtained from the herbal dealer Lukon Glads (Sadská, Czech Republic). A voucher specimen is deposited in the herbarium of the Faculty of Pharmacy in Hradec Králové.
Extraction of alkaloids:
Fresh bulbs (3 x 15 g) were extracted 3 times with EtOH (50 mL) at room temperature for 24 h. The solvent was evaporated under reduced pressure and the residue dissolved in 10 mL 2% HCl. After removing the neutral compounds with diethyl ether (3 x 15 mL), the extract was basified with 25% ammonia solution and the alkaloids extracted with EtOAc (3 x 15 mL). The organic solvent was evaporated and 10 mg of each alkaloid extract was removed for acetylcholinesterase and butyrylcholinesterase assay. The rest of the dry alkaloid fraction was dissolved in MeOH to a final concentration of 10 mg/mL for further analysis.
GC/MS analysis and identification of alkaloids:
The GC/MS analysis of underivatized alkaloids from Ch. fragrans was carried out on a gas chromatograph (Focus Thermo Scientific, USA) with a splitless injector (280°C) and a mass detector (200°C, GC-MS MD 800 Fisons, Manchester, UK). A DB-5MS column (30 m x 0.25 mm x 0.25 μm, Agilent Technologies Santa Clara, CA, USA) was used for separation. The temperature program was: 100 -180°C at 15°C/min, 1 min hold at 180°C and 180 -300°C at 5°C /min and 5 min hold at 300°C, detection range m/z 40-600. The injector temperature was 280°C. The flow-rate of carrier gas (helium) was 1 mL/min. A split ratio of 1:10 was used. The alkaloidal solution (1 μL) was injected. The alkaloids were identified by comparison of their MS with those in the NIST library, with those reported in the literature [3, 20, 22, 23, 25] , with commercially available standards (galanthamine, Changsha Organic), and with reference compounds isolated in our laboratory (galanthine, tazettine, lycoramine, epimacronine).
Preparation of red blood cells ghosts:
Ghosts were prepared from freshly drawn blood (taken from healthy volunteers), to which 1 mL of sodium citrate per 10 mL of blood was added, according to the method of Steck and Kant [27] , with slight modification. Briefly, plasma (HuBuChE) was removed from the whole blood by centrifugation at 4000 rpm in a Boeco U-32R centrifuge with a Hettich 1611 rotor. Red blood cells were transferred to 50 mL tubes and washed 3 times with 5 mM phosphate buffer (pH 7.4) containing 150 mM sodium chloride (12000 rpm, Avanti J-30I, rotor JA-30.50). The washed erythrocytes were stirred with 5 mM phosphate buffer (pH 7.4) for 10 mins to ensure lysis. The lysed cells were centrifuged at 20,000 rpm for 10 mins and then the ghosts (HuAChE) were washed 3 times with phosphate buffer.
Acetylcholinesterase and butyrylcholinesterase assay:
HuAChE and HuBuChE activities were determined with a modified method of Ellman et al. [28] at concentrations of 0.5, 2.5, 5, 12.5, 25, 50, 125, 250 and 500 μm/L ( Table 2) using acetylthiocholine iodide and butyrylthiocholine iodide as substrates, respectively. Briefly, 25-50 μL of either ghosts or plasma, 650 μL of DTNB and 25 μL of either the sample or appropriate solvent, as a blank sample, were added to the semi-micro cuvette. The reaction was initiated by addition of substrate (ATChI or BuTChI). The final proportion of DTNB to substrate was 1:1. The increase of absorbance at 436 nm (∆A) was measured for 1 min using a Shimadzu UV-1611 spectrophotometer. Each measurement was repeated 3 times. Galanthamine and huperzine A were used as positive standards [18] . The % inhibition was calculated according to the formula: %I = 100-(∆A BL /∆A SA )*100, where ∆A BL is increase of absorbance of blank sample and ∆A SA is increase of absorbance of the measured sample.
Statistical analysis:
The IC 50 values were calculated with the use of GraphPad Prism 5.02 software.
